Ueoka H - Search Results

1

Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer.

Takigawa N, Segawa Y, Ueoka H, Kiura K, Tabata M, Shibayama T, Takata I, Miyamoto H, Eguchi K, Harada M. Takigawa N, et al. Among authors: ueoka h. Cancer Chemother Pharmacol. 2000;46(4):272-8. doi: 10.1007/s002800000153. Cancer Chemother Pharmacol. 2000. PMID: 11052624 Clinical Trial.

2

[Treatment of small cell lung cancer in the elderly: the progress and limitation of chemotherapy].

Ohnoshi T, Ueoka H, Hino N, Yonei T, Horiguchi T, Kiura K, Moritaka T, Kodani T, Kamei H, Segawa Y, et al. Ohnoshi T, et al. Among authors: ueoka h. Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Feb;30(2):216-23. Nihon Kyobu Shikkan Gakkai Zasshi. 1992. PMID: 1318433 Japanese.

3

[Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer].

Shibayama T, Ohnoshi T, Ueoka H, Horiguchi T, Kodani T, Segawa Y, Maeda T, Miyatake K, Takigawa N, Kimura I. Shibayama T, et al. Among authors: ueoka h. Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Jun;30(6):1097-102. Nihon Kyobu Shikkan Gakkai Zasshi. 1992. PMID: 1324376 Japanese.

4

[New anthracycline analogues in the treatment of lung cancer].

Ueoka H, Ohnoshi T, Kimura I. Ueoka H, et al. Gan To Kagaku Ryoho. 1992 Nov;19(13):2146-9. Gan To Kagaku Ryoho. 1992. PMID: 1332624 Review. Japanese.

5

An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.

Kiura K, Ohnoshi T, Ueoka H, Takigawa N, Tabata M, Segawa Y, Shibayama T, Kimura I. Kiura K, et al. Among authors: ueoka h. Anticancer Drug Des. 1992 Dec;7(6):463-70. Anticancer Drug Des. 1992. PMID: 1337430

6

[Immunohistochemical detection of carcinoembryonic antigen and P-glycoprotein in small cell lung cancer at diagnosis and relapse, with special reference to the tissue expression of CEA and response to chemotherapy].

Ohnoshi T, Ueoka H, Segawa Y, Kiura K, Tabata M, Shibayama T, Maeda T, Miyatake K, Takigawa N, Kimura I. Ohnoshi T, et al. Among authors: ueoka h. Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Feb;30(2):262-9. Nihon Kyobu Shikkan Gakkai Zasshi. 1992. PMID: 1351108 Japanese.

7

Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line.

Takigawa N, Ohnoshi T, Ueoka H, Kiura K, Kimura I. Takigawa N, et al. Among authors: ueoka h. Acta Med Okayama. 1992 Jun;46(3):203-12. doi: 10.18926/AMO/32669. Acta Med Okayama. 1992. PMID: 1354408

8

[A case of locally advanced esophageal cancer effectively treated with concurrent chemotherapy and radiotherapy].

Segawa Y, Ohnoshi T, Ueoka H, Kiura K, Horiguchi T, Kodani T, Kamei H, Tabata M, Shibayama T, Maeda T, et al. Segawa Y, et al. Among authors: ueoka h. Gan To Kagaku Ryoho. 1992 Apr;19(4):529-32. Gan To Kagaku Ryoho. 1992. PMID: 1373050 Japanese.

9

Comparison of antitumor activity of new anthracycline analogues, ME2303, KRN8602, and SM5887 using human lung cancer cell lines.

Takigawa N, Ohnoshi T, Ueoka H, Kiura K, Kimura I. Takigawa N, et al. Among authors: ueoka h. Acta Med Okayama. 1992 Aug;46(4):249-56. doi: 10.18926/AMO/32631. Acta Med Okayama. 1992. PMID: 1442149

10

Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.

Ohnoshi T, Hiraki S, Ueda N, Fujii M, Machida K, Ueoka H, Kawahara S, Kozuka A, Kiura K, Moritaka T, et al. Ohnoshi T, et al. Among authors: ueoka h. Acta Med Okayama. 1991 Oct;45(5):357-61. doi: 10.18926/AMO/32200. Acta Med Okayama. 1991. PMID: 1661559 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters